What is Zacks Research's Forecast for Bruker Q4 Earnings?

Bruker Co. (NASDAQ:BRKR - Free Report) - Research analysts at Zacks Research increased their Q4 2025 earnings per share (EPS) estimates for Bruker in a research report issued on Thursday, March 6th. Zacks Research analyst R. Department now expects that the medical research company will post earnings per share of $0.96 for the quarter, up from their prior forecast of $0.92. The consensus estimate for Bruker's current full-year earnings is $2.69 per share. Zacks Research also issued estimates for Bruker's Q1 2026 earnings at $0.53 EPS and Q4 2026 earnings at $1.07 EPS.

Other equities analysts have also issued research reports about the company. Guggenheim restated a "buy" rating on shares of Bruker in a research note on Monday, February 24th. Stifel Nicolaus cut their price target on Bruker from $70.00 to $57.00 and set a "hold" rating on the stock in a research note on Friday, February 14th. UBS Group initiated coverage on Bruker in a research note on Tuesday, December 10th. They set a "neutral" rating and a $66.00 price target on the stock. Bank of America lifted their target price on Bruker from $78.00 to $80.00 and gave the company a "buy" rating in a research note on Friday, December 13th. Finally, Barclays decreased their target price on Bruker from $69.00 to $65.00 and set an "overweight" rating for the company in a report on Monday, February 10th. Six research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of $70.50.

Remove Ads

Bruker Stock Down 0.1 %

Shares of Bruker stock traded down $0.04 during trading on Monday, hitting $45.52. 51,253 shares of the stock traded hands, compared to its average volume of 1,259,791. The firm has a market cap of $6.91 billion, a P/E ratio of 60.31, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18. The company has a current ratio of 1.60, a quick ratio of 0.77 and a debt-to-equity ratio of 1.15. Bruker has a 52-week low of $44.89 and a 52-week high of $94.86. The stock's fifty day simple moving average is $54.48 and its 200 day simple moving average is $58.76.

Bruker (NASDAQ:BRKR - Get Free Report) last released its earnings results on Thursday, February 13th. The medical research company reported $0.76 earnings per share for the quarter, topping analysts' consensus estimates of $0.75 by $0.01. Bruker had a return on equity of 21.01% and a net margin of 3.36%.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. True Wealth Design LLC lifted its holdings in Bruker by 4,636.4% in the third quarter. True Wealth Design LLC now owns 521 shares of the medical research company's stock valued at $36,000 after acquiring an additional 510 shares during the period. Eagle Bay Advisors LLC increased its position in shares of Bruker by 2,324.1% in the fourth quarter. Eagle Bay Advisors LLC now owns 703 shares of the medical research company's stock valued at $41,000 after buying an additional 674 shares in the last quarter. UMB Bank n.a. increased its position in shares of Bruker by 37.5% in the fourth quarter. UMB Bank n.a. now owns 909 shares of the medical research company's stock valued at $53,000 after buying an additional 248 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Bruker by 47.5% in the fourth quarter. GAMMA Investing LLC now owns 1,279 shares of the medical research company's stock valued at $75,000 after buying an additional 412 shares in the last quarter. Finally, Quadrant Capital Group LLC increased its position in shares of Bruker by 18.2% in the fourth quarter. Quadrant Capital Group LLC now owns 1,273 shares of the medical research company's stock valued at $75,000 after buying an additional 196 shares in the last quarter. 79.52% of the stock is owned by institutional investors and hedge funds.

Bruker Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, March 28th. Shareholders of record on Monday, March 17th will be issued a $0.05 dividend. This represents a $0.20 dividend on an annualized basis and a yield of 0.44%. The ex-dividend date of this dividend is Monday, March 17th. Bruker's payout ratio is presently 26.32%.

About Bruker

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.